Skip to main content

Q-VANT’s mission is to meet the growing global vaccine market demand for saponin adjuvants, to enable new vaccine development and assure supply chain continuity to existing vaccines from an industrial scale perspective.

Q-SAPTM Technology for Flexible Biomass Sourcing

The Q-SAP platform enables varied Quillaja sourcing options and drives extremely effective outputs of high-quality saponins. Through Q-SAP technology, Q-VANT can consistently produce high quality and consistency adjuvants from any Quillaja plant material, eliminating the supply dependence and risk of using tree bark.

High Density Plantations

Q-VANT has access to high-density plantations guaranteeing large volumes and reduced cost to avoid dependence on sourcing from the native forest. The raw material from plantations is extremely cost effective when compared to other plant production methods including in-vitro plant material and-or cell culture fermentation. This approach allows Q-VANT to supply billion of doses for global health vaccines such as Malaria, TB and others.

Quillaja Tree Plantation

Q-SAP Technology

Q-SAP™ – Quillaja Sustainable Adjuvant Platform is a technology platform combining learning techniques and a proprietary multi-step purification process.